CKAP5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.968600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.650000E-01
Normal-vs-Stage2
5.641800E-01
Normal-vs-Stage3
3.116200E-01
Normal-vs-Stage4
4.970000E-01
Stage1-vs-Stage2
3.963200E-01
Stage1-vs-Stage3
2.197000E-01
Stage1-vs-Stage4
4.515800E-01
Stage2-vs-Stage3
7.137500E-02
Stage2-vs-Stage4
5.236400E-01
Stage3-vs-Stage4
2.002000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.953000E-01
Normal-vs-AfricanAmerican
8.959400E-01
Normal-vs-Asian
7.837000E-01
Caucasian-vs-AfricanAmerican
5.304800E-01
Caucasian-vs-Asian
7.010000E-01
AfricanAmerican-vs-Asian
7.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.731200E-01
Normal-vs-Female
6.374800E-01
Male-vs-Female
6.348000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.379200E-01
Normal-vs-Age(41-60Yrs)
2.497200E-01
Normal-vs-Age(61-80Yrs)
7.535400E-01
Normal-vs-Age(81-100Yrs)
8.997000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.773760E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.156200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.735800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.289700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.108300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.358600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.725800E-01
Normal-vs-Daily Drinker
8.761400E-01
Normal-vs-Weekly Drinker
5.680600E-01
Normal-vs-Occasional Drinker
2.585800E-01
Normal-vs-Social Drinker
3.781000E-01
Non Drinker-vs-Daily Drinker
7.714800E-01
Non Drinker-vs-Weekly Drinker
3.051800E-01
Non Drinker-vs-Occasional Drinker
2.939900E-02
Non Drinker-vs-Social Drinker
9.301800E-02
Daily Drinker-vs-Weekly Drinker
5.157400E-01
Daily Drinker-vs-Occasional Drinker
1.023830E-01
Daily Drinker-vs-Social Drinker
2.242000E-01
Weekly Drinker-vs-Occasional Drinker
3.661800E-01
Weekly Drinker-vs-Social Drinker
5.840800E-01
Occasional Drinker-vs-Social Drinker
7.511400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.546800E-01
Normal-vs-Grade 2
8.153200E-01
Normal-vs-Grade 3
7.714000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.337940E-02
Grade 1-vs-Grade 3
4.802900E-03
Grade 1-vs-Grade 4
9.546800E-01
Grade 2-vs-Grade 3
3.287800E-01
Grade 2-vs-Grade 4
8.153200E-01
Grade 3-vs-Grade 4
7.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.069200E-01
Normal-vs-NonDiabetic
5.653800E-01
Diabetic-vs-NonDiabetic
3.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.564000E-01
Normal-vs-NoPancreatitis
6.631000E-01
Pancreatitis-vs-NoPancreatitis
2.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.091400E-01
Normal-vs-N1
6.186000E-01
N0-vs-N1
6.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.544380E-01
Normal-vs-TP53-NonMutant
7.547800E-01
TP53-Mutant-vs-TP53-NonMutant
1.035890E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
